Galderma will present the latest updates from its innovative aesthetics portfolio at the International Master Course on Aging Science (IMCAS) World Congress 2025 on January 30 ? February 1 in Paris, ...

Galderma (SWX:GALD) announced today the launch of its hyaluronic acid injectable filler, Restylane ® VOLYMEtm ... premium range of aesthetics products to meet the varied and individual needs ...

L’Oréal just announced it acquired a 10% stake in Galderma, characterized as a “pure play dermatology leader” in injectibles with Botox-competitor Dysport, and Restylane filler brands.

New data suggest Restylane Lyft or Contour in combination with Sculptra corrects contour deficiencies in patients ...

"We initiated this trial because we have the unique expertise, capability, and products needed to rapidly respond to the evolving ... loss medicines In a phase IV clinical trial conducted in the U.S., ...

1 Restylane SHAYPE is ... approach for combining aesthetic products to maximize patient outcomes. More details on scientific presentations supported by Galderma at AMWC can be found here ...

4 “We initiated this trial because we have the unique expertise, capability, and products ... the U.S., Galderma investigated the efficacy, safety, and patient satisfaction of Restylane LyftTM ...

"By joining forces with Galderma Aesthetics, we are bringing cutting-edge treatments like Restylane Skinboosters to our patients. This innovative treatment hydrates, smooths and rejuvenates the ...

ZUG, Switzerland, June 19, 2024--Galderma today announced that the Swedish Medical Products Agency (Läkemedelsverket ... acid injectable filler, Restylane® VOLYME™ in China.